Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

Similar articles for PubMed (Select 23561290)

1.

Virus-like particles: promising platforms with characteristics of DIVA for veterinary vaccine design.

Liu F, Wu X, Li L, Ge S, Liu Z, Wang Z.

Comp Immunol Microbiol Infect Dis. 2013 Jul;36(4):343-52. doi: 10.1016/j.cimid.2013.02.002. Epub 2013 Apr 3. Review.

PMID:
23561290
2.

Enveloped virus-like particle platforms: vaccines of the future?

Pitoiset F, Vazquez T, Bellier B.

Expert Rev Vaccines. 2015 Jul;14(7):913-5. doi: 10.1586/14760584.2015.1046440. Epub 2015 May 12.

PMID:
25968245
3.

Suggested guidelines for vaccination of pigs in Korea.

Lee WH, Yoo HS.

Clin Exp Vaccine Res. 2015 Jan;4(1):119-20. doi: 10.7774/cevr.2015.4.1.119. Epub 2015 Jan 30.

4.

Progress and hurdles in the development of influenza virus-like particle vaccines for veterinary use.

Lee DH, Park JK, Song CS.

Clin Exp Vaccine Res. 2014 Jul;3(2):133-9. doi: 10.7774/cevr.2014.3.2.133. Epub 2014 Jun 20. Review.

5.

Nanotechnology-based approaches for the development of diagnostics, therapeutics, and vaccines.

Srinivasan A, Rastogi A, Ayyavoo V, Srivastava S.

Monoclon Antib Immunodiagn Immunother. 2014 Jun;33(3):186-91. doi: 10.1089/mab.2014.0045. Review.

6.

Subviral particle as vaccine and vaccine platform.

Tan M, Jiang X.

Curr Opin Virol. 2014 Jun;6:24-33. doi: 10.1016/j.coviro.2014.02.009. Epub 2014 Mar 21. Review.

7.

Virus-like particle-based human vaccines: quality assessment based on structural and functional properties.

Zhao Q, Li S, Yu H, Xia N, Modis Y.

Trends Biotechnol. 2013 Nov;31(11):654-63. doi: 10.1016/j.tibtech.2013.09.002. Epub 2013 Oct 11. Review.

PMID:
24125746
8.

[Production and evaluation of immunologic characteristics of mzNLA-3, a non-infectious HIV-1 clone with a large deletion in the pol sequence].

Aghasadeghi MR, Zabihollahi R, Sadat SM, Salehi M, Ashtiani SH, Namazi R, Kashanizadeh N, Azadmanesh K.

Mol Biol (Mosk). 2013 Mar-Apr;47(2):258-66. Russian.

PMID:
23808159
9.

Design of novel vaccines based on virus-like particles or chimeric virions.

Bárcena J, Blanco E.

Subcell Biochem. 2013;68:631-65. doi: 10.1007/978-94-007-6552-8_21. Review.

PMID:
23737067
11.

H9N2 avian influenza virus in Korea: evolution and vaccination.

Lee DH, Song CS.

Clin Exp Vaccine Res. 2013 Jan;2(1):26-33. doi: 10.7774/cevr.2013.2.1.26. Epub 2013 Jan 15.

12.

M2e-displaying virus-like particles with associated RNA promote T helper 1 type adaptive immunity against influenza A.

Ibañez LI, Roose K, De Filette M, Schotsaert M, De Sloovere J, Roels S, Pollard C, Schepens B, Grooten J, Fiers W, Saelens X.

PLoS One. 2013;8(3):e59081. doi: 10.1371/journal.pone.0059081. Epub 2013 Mar 18.

13.

Vaccine delivery system for tuberculosis based on nano-sized hepatitis B virus core protein particles.

Dhanasooraj D, Kumar RA, Mundayoor S.

Int J Nanomedicine. 2013;8:835-43. doi: 10.2147/IJN.S40238. Epub 2013 Feb 25.

14.

[Role of vaccination in animal health].

Pastoret PP.

Bull Acad Natl Med. 2012 Mar;196(3):589-90, 619-20. French.

PMID:
23472348
15.

Self-adjuvanting modular virus-like particles for mucosal vaccination against group A streptococcus (GAS).

Rivera-Hernandez T, Hartas J, Wu Y, Chuan YP, Lua LH, Good M, Batzloff MR, Middelberg AP.

Vaccine. 2013 Apr 8;31(15):1950-5. doi: 10.1016/j.vaccine.2013.02.013. Epub 2013 Feb 17.

PMID:
23422147
16.

Human rotavirus virus-like particle vaccines evaluated in a neonatal gnotobiotic pig model of human rotavirus disease.

Azevedo MP, Vlasova AN, Saif LJ.

Expert Rev Vaccines. 2013 Feb;12(2):169-81. doi: 10.1586/erv.13.3. Review.

PMID:
23414408
17.

Virus-like particle-based vaccines against hepatitis C virus infection.

Bellier B, Klatzmann D.

Expert Rev Vaccines. 2013 Feb;12(2):143-54. doi: 10.1586/erv.13.10. Review.

PMID:
23414406
18.

Virus-like particles for the prevention of human papillomavirus-associated malignancies.

Wang JW, Roden RB.

Expert Rev Vaccines. 2013 Feb;12(2):129-41. doi: 10.1586/erv.12.151. Review.

19.

The application of virus-like particles to human diseases.

Buonaguro F, Buonaguro L.

Expert Rev Vaccines. 2013 Feb;12(2):99. doi: 10.1586/erv.12.154. No abstract available.

PMID:
23414399
20.

The use of transient expression systems for the rapid production of virus-like particles in plants.

Thuenemann EC, Lenzi P, Love AJ, Taliansky M, Bécares M, Zuñiga S, Enjuanes L, Zahmanova GG, Minkov IN, Matić S, Noris E, Meyers A, Hattingh A, Rybicki EP, Kiselev OI, Ravin NV, Eldarov MA, Skryabin KG, Lomonossoff GP.

Curr Pharm Des. 2013;19(31):5564-73. Review.

PMID:
23394559
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk